Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
30392
Description
Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00794261
Lien
https://clinicaltrials.gov/show/NCT00794261
Mots-clés
Versions (2)
- 01/06/2018 01/06/2018 -
- 01/06/2018 01/06/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
1 juin 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Lymphoma NCT00794261
Eligibility Lymphoma NCT00794261
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT00794261
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
male or female patients aged ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Lymphoma | Multiple Myeloma
Item
patients with histologically confirmed lymphoma or myeloma
boolean
C0024299 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
C0026764 (UMLS CUI [2])
High-dose chemotherapy
Item
treatment with high-dose chemotherapy before inclusion
boolean
C1328050 (UMLS CUI [1])
Melphalan High dose | Multiple Myeloma
Item
intensification with high dose melphalan for patients with myeloma
boolean
C0025241 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0026764 (UMLS CUI [2])
C0444956 (UMLS CUI [1,2])
C0026764 (UMLS CUI [2])
Transplantation Conditioning | Exception Whole-Body Irradiation First Relapse Hodgkin Disease | Other Coding | Consolidation therapy Quantity
Item
whatever the conditioning regimen, except tbi for patients with 1st relapse of hodgkin's lymphoma or with mnhl nb: patients having received two intensification courses are eligible if there has been more than 100 days between courses.
boolean
C0376450 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0043162 (UMLS CUI [2,2])
C4054953 (UMLS CUI [2,3])
C0019829 (UMLS CUI [2,4])
C3846158 (UMLS CUI [3])
C1511484 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
C1705847 (UMLS CUI [2,1])
C0043162 (UMLS CUI [2,2])
C4054953 (UMLS CUI [2,3])
C0019829 (UMLS CUI [2,4])
C3846158 (UMLS CUI [3])
C1511484 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
Primary sclerosing cholangitis Autologous Transplantation
Item
autologous psc transplantation at the time of inclusion
boolean
C0566602 (UMLS CUI [1,1])
C0040736 (UMLS CUI [1,2])
C0040736 (UMLS CUI [1,2])
Reinjection Other Coding
Item
reinjection of ≥ 2.106 cd34/kg
boolean
C0444600 (UMLS CUI [1,1])
C3846158 (UMLS CUI [1,2])
C3846158 (UMLS CUI [1,2])
Hospitalization | Aplasia Recovery | Polymorphonuclear neutrophil Count
Item
patients hospitalized in the investigator center throughout the procedure until recovery from aplasia (pnn > 0.5 g/l)
boolean
C0019993 (UMLS CUI [1])
C0243065 (UMLS CUI [2,1])
C2004454 (UMLS CUI [2,2])
C0027950 (UMLS CUI [3,1])
C0750480 (UMLS CUI [3,2])
C0243065 (UMLS CUI [2,1])
C2004454 (UMLS CUI [2,2])
C0027950 (UMLS CUI [3,1])
C0750480 (UMLS CUI [3,2])
Affiliation mandatory Health Insurance
Item
mandatory affiliation with a health insurance system
boolean
C1510825 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0021682 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,2])
C0021682 (UMLS CUI [1,3])
Comprehension French language | Able to read French language | Able to write French language
Item
patients able to understand, read and write french
boolean
C0233733 (UMLS CUI [1,1])
C0376246 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
C0584993 (UMLS CUI [3,1])
C0376246 (UMLS CUI [3,2])
C0376246 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
C0584993 (UMLS CUI [3,1])
C0376246 (UMLS CUI [3,2])
Informed Consent
Item
signed, written informed consent
boolean
C0021430 (UMLS CUI [1])
Whole-Body Irradiation During Conditioning
Item
tbi during conditioning
boolean
C0043162 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0376450 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,2])
C0376450 (UMLS CUI [1,3])
Intolerance Severe Growth Factor Study | Intolerance Severe Growth Factor Component
Item
severe intolerance to the growth factor under study, or hypersensitivity to one of their components
boolean
C0231199 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0018284 (UMLS CUI [1,3])
C2603343 (UMLS CUI [1,4])
C0231199 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0018284 (UMLS CUI [2,3])
C1705248 (UMLS CUI [2,4])
C0205082 (UMLS CUI [1,2])
C0018284 (UMLS CUI [1,3])
C2603343 (UMLS CUI [1,4])
C0231199 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0018284 (UMLS CUI [2,3])
C1705248 (UMLS CUI [2,4])
Immunosuppression
Item
immunosuppressive syndrome
boolean
C4048329 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Follow-up Difficult
Item
difficult follow-up
boolean
C3274571 (UMLS CUI [1,1])
C0332218 (UMLS CUI [1,2])
C0332218 (UMLS CUI [1,2])
Cognition Disorders | Mental disorders
Item
documented history of cognitive or psychiatric disorders
boolean
C0009241 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0004936 (UMLS CUI [2])
Study Subject Participation Status | Biomedical Research | Consideration Participation Biomedical Research
Item
participation or consideration of participation in another biomedical study during the follow-up period of the present trial.
boolean
C2348568 (UMLS CUI [1])
C0005540 (UMLS CUI [2])
C0518609 (UMLS CUI [3,1])
C0679823 (UMLS CUI [3,2])
C0005540 (UMLS CUI [3,3])
C0005540 (UMLS CUI [2])
C0518609 (UMLS CUI [3,1])
C0679823 (UMLS CUI [3,2])
C0005540 (UMLS CUI [3,3])